Basit öğe kaydını göster

ENGOT-en9/LEAP-001: A phase III study of first-line pembrolizumab plus lenvatinib versus chemotherapy in advanced or recurrent endometrial cancer.

dc.contributor.authorMarth, Christian
dc.contributor.authorVulsteke, Christof
dc.contributor.authorPerez, Maria Jesus Rubio
dc.contributor.authorMakker, Vicky
dc.contributor.authorBraicu, Elena Ioana
dc.contributor.authorMcNeish, Iain A.
dc.contributor.authorMadry, Radoslaw
dc.contributor.authorAyhan, Ali
dc.contributor.authorHasegawa, Kosei
dc.contributor.authorWu, Xiaohua
dc.contributor.authorDutta, Lea
dc.contributor.authorXu, Cindy
dc.contributor.authorKeefe, Stephen Michael
dc.contributor.authorLee, John J.
dc.contributor.authorPignata, Sandro
dc.date.accessioned2021-03-05T09:09:44Z
dc.date.available2021-03-05T09:09:44Z
dc.date.issued2020
dc.identifier.issn0732-183Xen_US
dc.identifier.urihttp://hdl.handle.net/11727/5511
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleENGOT-en9/LEAP-001: A phase III study of first-line pembrolizumab plus lenvatinib versus chemotherapy in advanced or recurrent endometrial cancer.en_US
dc.typeconferenceObjecten_US
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGYen_US
dc.identifier.volume38en_US
dc.identifier.issue15en_US
dc.identifier.wos000560368309198en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster